Kriya Therapeutics, Inc. — Form D/A

Kriya Therapeutics, Inc. of MORRISVILLE, NC, a company, filed a Form D amendment with the SEC on 2025-09-10. The offering totals $320.8M, of which $320.8M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (21)

NameRoleLocation
Ryan GallagherDirectorCorona Del Mar, CA
Trit GargDirectorMorrisville, NC
Roger JeffsDirectorMorrisville, NC
Keith ManchesterDirectorMorrisville, NC
James MomtazeeDirectorMenlo Park, CA
Ilan OrenDirectorMorrisville, NC
Akshay RaiDirectorMorrisville, NC
Saira RamasastryDirectorRaleigh, NC
Shankar RamaswamyDirectorMorrisville, NC
Neelaksh VarshneyDirectorMorrisville, NC
Katherine EadeExecutive OfficerMorrisville, NC
Brian FurmanskiExecutive OfficerMorrisville, NC
Curt HerbertsExecutive OfficerMorrisville, NC
Britt PettyExecutive OfficerMorrisville, NC
Shankar RamaswamyExecutive OfficerMorrisville, NC
Michele StoneExecutive OfficerMorrisville, NC
DANIEL CHENExecutive OfficerSan Mateo, CA
Dana JohnsonExecutive OfficerPalo Alto, CA
Neera RavindranExecutive OfficerRedwood City, CA
Ilise LombardoExecutive OfficerRedwood City, CA
C.R. SincockDirectorRedwood City, CA

Other filings by this issuer (6)

FiledFormOfferingSold
2025-08-15D$313.3M$313.3M
2023-07-27D/A$432.0M$361.8M
2022-05-24D$300.5M$270.5M
2021-07-14D$100.0M$100.0M
2020-08-18D/A$87.6M$87.6M
2020-05-19D$85.6M$85.6M

More